Citation: A. Shakespeare et G. Simeon, ECONOMIC-ANALYSIS OF EPILEPSY TREATMENT - A COST MINIMIZATION ANALYSIS COMPARING CARBAMAZEPINE AND LAMOTRIGINE IN THE UK, Seizure, 7(2), 1998, pp. 119-125
Citation: G. Simeon, HEALTH-CARE POLICY AND ITS IMPACT ON INTERVENTIONAL CARDIOLOGY - REIMBURSEMENT, BUDGETS AND FUTURE-DEVELOPMENTS, The Journal of invasive cardiology, 9, 1997, pp. 28-29
Citation: G. Simeon et Gl. Bakris, SOCIOECONOMIC IMPACT OF DIABETIC NEPHROPATHY - CAN WE IMPROVE THE OUTCOME, Journal of hypertension, 15, 1997, pp. 77-82
Citation: R. Berzon et al., QUALITY-OF-LIFE MEASUREMENT FOR DECISIONS ABOUT THE USE OF NEW THERAPEUTIC DRUGS - A TALE OF 2 NEEDS, Quality of life research, 3(1), 1994, pp. 46-46